Technology ID
TAB-4617
Influenza A/H9 viruses Real-time (RT)-PCR Assay for Detection and Characterization of Influenza A/H9 Viruses
E-Numbers
E-021-2014-0
Lead Inventor
Lindstrom, Stephen
Lead IC
CDC
Co-Inventors
Wu, Kai-Hui
Berman, LaShondra
Warnes, Christine
Shu, Bo
ICs
CDC
Applications
Research Materials
Diagnostics
Therapeutic Areas
Infectious Disease
Development Stages
Analytical Assay Performance Stage
Research Products
Research Equipment
This technology includes an optimized influenza A/H9 virus real-time (RT)-PCR assay for detection and characterization influenza A/H9 viruses, which are considered to be one of the most likely candidates to cause an influenza pandemic in humans. The H9 real-time RT-PCR assay will be in compliment with CDC human Influenza Viruses RT-PCR Detection and Characterization Panel to detect of A/H9 influenza viruses.
Commercial Applications
The assay may be licensed to commercial entities to manufacture and sell commercial reagents to research and clinical laboratories.
Competitive Advantages
The H9 real-time RT-PCR assay allows to qualitative detection of A/H9 influenza viruses in the shortest time with the highest sensitivity and specificity.
Licensing Contact: